SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

XGN

EXAGEN INC.
NEUTRAL
Impact 3/10
Horizonweeks Processed3d 18h ago SEC0001193805-26-001475
Passive stake amendment
Actionable Insight • Neutral

Monitor for any future conversion to a Schedule 13D (activist filing) or further stake increases. The passive nature and sub-5% holding suggest no near-term catalyst, but the accumulation by an individual investor over several months warrants attention.

DirectionNeutral
Confidencehigh
Horizonweeks

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Jorey Chernett filed an amended Schedule 13G disclosing beneficial ownership of 886,148 shares of Exagen Inc. (XGN), representing 3.47% of outstanding shares as of November 13, 2026. The stake increased from 0 shares in the prior filing (May 2026), indicating a new passive position was built over the past six months. The filing remains passive and below the 5% threshold, with no indication of activist intent.

Key Financial Metrics

Stake
3.47%
Investor
Chernett Jorey

Key Facts

  • Jorey Chernett reported beneficial ownership of 886,148 shares of Exagen Inc. common stock.
  • The stake represents 3.47% of 25,513,497 shares outstanding as of November 3, 2026.
  • The filing is an amendment to Schedule 13G, indicating passive investment intent.
  • The prior filing by Chernett (May 20, 2026) showed 0 shares, meaning this is a new position built over the last six months.
  • The investor certifies the securities were not acquired to change or influence control of the issuer.

Financial Impact

886,148 shares valued at approximately $4.5 million based on market cap of $128M and 25.5M shares outstanding (approx. $5.02/share).

ownership concentration

Risk Factors

  • The filing is passive; no activist or control intent is indicated.
  • Stake is below 5%, so no mandatory disclosure of further changes unless crossing the 5% threshold.
  • No information on cost basis or investment horizon is provided.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001193805-26-001475
Document: 0001193805-26-001475-index.html0001193805-26-001475
Document: 0001193805-26-001475.txt0001193805-26-001475

Track record

17 reports on XGN

Performance horizon

6 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +67.09% at T+60 after the May 11, 2026 report. 7 of 7 went positive at some point.

Filters
  1. Nov 17, 2026today 424B5 Bearish 5/10 Entry $3.69 Now $3.76 −1.90% settles Dec 17
  2. Nov 13, 20263d ago SC 13G/A Neutral 3/10 Viewing Entry $4.33 Now $3.76 −13.16% settles Dec 15
  3. Nov 13, 20264d ago SC 13G/A Neutral 2/10 Entry $5.02 Now $3.76 −25.10% settles Dec 15
  4. Nov 12, 20265d ago Insider Buy Neutral 4/10 Entry $4.41 Now $3.76 −14.74% settles Dec 11
  5. Nov 10, 20266d ago Insider Buy Mixed 4/10 Entry $5.04 Now $3.76 −25.32% settles Dec 10
  6. Nov 10, 20267d ago S-3 Bearish 5/10 Entry $5.26 Now $3.76 +28.52% settles Dec 9
  7. Nov 10, 20267d ago Press Release Neutral 4/10 Entry $5.26 Now $3.76 −28.52% settles Dec 9
  8. Oct 20, 202628d ago Insider Cluster Mixed 4/10 Entry $7.41 Now $3.76 −49.26% due Nov 17
  9. Aug 4, 202615w ago 8-K Bullish 7/10 Entry $6.45 to $7.12 Now $3.76 −41.71% ▲ +10.39% +11.63% vs SPY
  10. May 11, 202627w ago 8-K Bullish 6/10 No price data
Showing 10 of 17

US Market Status

Market Closed · Opens Wed (16h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026